Skip to main content
Heart logoLink to Heart
editorial
. 1999 Dec;82(6):651–652. doi: 10.1136/hrt.82.6.651

Taming platelets in coronary stenting: ticlopidine out, clopidogrel in?

C BROOKES, U SIGWART
PMCID: PMC1729214  PMID: 10573482

Full Text

The Full Text of this article is available as a PDF (77.7 KB).

Figure 1  .

Figure 1  

Design and results of the CLASSICS trial: 335 patients in each group were treated for 28 days. Primary end point: cluster of major bleeding, neutropenia, thrombocytopenia, and other early discontinuation for non-cardiac cause. Secondary end point: cluster of major cardiac events (myocardial infarction, sudden death, subacute thrombosis).


Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES